Opportunities for chemoprophylaxis in children with culture-confirmed tuberculosis

Annals of Tropical Paediatrics

Volumn 31, Issue 4, 2011, Pages 301-310

  Du Preez, K ^a   Hesseling, A C ^a   Mandalakas, A M ^a,c   Marais, B J ^d,e   Schaaf, H S ^a,b  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SYDNEY CHILDREN'S HOSPITAL   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; ETHIONAMIDE; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADOLESCENT; ARTICLE; BACTERIUM CULTURE; CHILD; COMMUNITY CARE; CONTROLLED STUDY; DRUG SENSITIVITY; EXTRAPULMONARY TUBERCULOSIS; FATHER; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MILIARY TUBERCULOSIS; MORTALITY; MOTHER; MULTIDRUG RESISTANT TUBERCULOSIS; POST EXPOSURE PROPHYLAXIS; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; TERTIARY HEALTH CARE; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOUS MENINGITIS; VULNERABLE POPULATION;

ADOLESCENT; ANTITUBERCULAR AGENTS; CHEMOPREVENTION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; TUBERCULOSIS;

EID: 80055034801     PISSN: 02724936     EISSN: 14653281     Source Type: Journal    
DOI: 10.1179/1465328111Y.0000000035     Document Type: Article

References (33)

1. Comstock GW, Baum C, Snider DE Jr. Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies. Am Rev Respir Dis 1979; 119:827-30.
2. Bright-Thomas R, Nandwani S, Smith J, Morris JA, Ormerod LP. Effectiveness of 3 months of rifampicin and isoniazid chemoprophylaxis for the treatment of latent tuberculosis infection in children. Arch Dis Child 2010; 95:600-2.
3. Committee on Prophylaxis, International Union Against Tuberculosis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull WHO 1982; 60:555-64.
4. Smieja M, Marchetti C, Cook D, Smaill F. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database of Systematic Reviews 1999.
5. World Health Organization. Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in children. WHO/HTM/TB/2006.371. Geneva: WHO, 2006.
6. Department of Health, South Africa. Tuberculosis Control Programme: Practical Guidelines. Pretoria: Department of Health, 2006.
7. Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004; 8:392-402.
8. Hesseling AC, Cotton MF, Jennings T, et al. High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis 2009; 48:108-14.
9. Van Wyk SS, Hamade H, Hesseling AC, Beyers N, Enarson DA, Mandalakas AM. Recording isoniazid preventive therapy delivery to children: operational challenges. Int J Tuberc Lung Dis 2010; 14:650-3.
10. Schaaf HS, Marais BJ, Whitelaw A, et al. Cultureconfirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases. BMC Infect Dis 2007; 7:140.
11. Nicol MP, Davies MA, Wood K, et al. Comparison of T-SPOT.TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting. Pediatrics 2009; 123:38-43.
12. van Zyl S, Marais BJ, Hesseling AC, Gie RP, Beyers N, Schaaf HS. Adherence to anti-tuberculosis chemoprophylaxis and treatment in children. Int J Tuberc Lung Dis 2006; 10:13-18.
13. Marais BJ, van Zyl S, Schaaf HS, van Aardt M, Gie RP, Beyers N. Adherence to isoniazid preventive chemotherapy: a prospective community based study. Arch Dis Child 2006; 91:762-5.
14. Claessens NJ, Gausi FF, Meijnen S, Weismuller MM, Salaniponi FM, Harries AD. Screening childhood contacts of patients with smear-positive pulmonary tuberculosis in Malawi. Int J Tuberc Lung Dis 2002; 6:362-4.
15. Nguyen TH, Odermatt P, Slesak G, Barennes H. Risk of latent tuberculosis infection in children living in households with tuberculosis patients: a cross sectional survey in remote northern Lao People's Democratic Republic. BMC Infect Dis 2009; 9:96.
16. Zachariah R, Spielmann MP, Harries AD, et al. Passive versus active tuberculosis case finding and isoniazid preventive therapy among household contacts in a rural district of Malawi. Int J Tuberc Lung Dis 2003; 7:1033-9.
17. Nyirenda M, Sinfield R, Haves S, Molyneux EM, Graham SM. Poor attendance at a child TB contact clinic in Malawi. Int J Tuberc Lung Dis 2006; 10: 585-7.
18. Western Cape Provincial EPI Vaccination Survey, 2005. http://www.capegateway.gov.za/Text/2007/6/cd_volume_7_childhood_diseases_overview. pdf.
19. Schaaf HS, Marais BJ, Hesseling AC, Brittle W, Donald PR. Surveillance of antituberculosis drug resistance among children from the Western Cape Province of South Africa - an upward trend. Am J Public Health 2009; 99:1486-90.
20. Sneag DB, Schaaf HS, Cotton MF, Zar HJ. Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases. Pediatr Infect Dis J 2007; 26:1142-6.
21. Gomes VF, Andersen A, Wejse C, et al. Impact of tuberculosis exposure at home on mortality in children under 5 years of age in Guinea-Bissau. Thorax 2011; 66:163-7.
22. Curry FJ. Prophylactic effect of isoniazid in young tuberculin reactors. N Engl J Med 1967; 277:562-7.
23. Hsu KH. Isoniazid in the prevention and treatment of tuberculosis. A 20-year study of the effectiveness in children. JAMA 1974; 229:528-33.
24. Debre R, Perdrizet S, Lotte A, Naveau M, Lert F. Isoniazid chemoprophylaxis of latent primary tuberculosis: in five trial centres in France from 1959 to 1969. Int J Epidemiol 1973; 2:153-60.
25. Zar HJ, Cotton MF, Strauss S, et al. Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomized controlled trial. Br Med J 2007; 334:136-42.
26. World Health Organization. Rapid Advice: Treatment of Tuberculosis in Children. Geneva: WHO, 2010.
27. Sinfield R, Nyirenda M, Haves S, Molyneux EM, Graham SM. Risk factors for TB infection and disease in young childhood contacts in Malawi. Ann Trop Paediatr 2006; 26:205-13.
28. Lienhardt C, Sillah J, Fielding K, et al. Risk factors for tuberculosis infection in children in contact with infectious tuberculosis cases in the Gambia, West Africa. Pediatrics 2003; 111:e608-14.
29. Kenyon TA, Creek T, Laserson K, et al. Risk factors for transmission of Mycobacterium tuberculosis from HIV-infected tuberculosis patients, Botswana. Int J Tuberc Lung Dis 2002; 6:843-50.
30. Rathi SK, Akhtar S, Rahbar MH, Azam SI. Prevalence and risk factors associated with tuberculin skin test positivity among household contacts of smear-positive pulmonary tuberculosis cases in Umerkot, Pakistan. Int J Tuberc Lung Dis 2002; 6:851-7.
31. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIVinfected infants. N Engl J Med 2008; 359:2233-44.
32. Hesseling AC, Westra AE, Werschkull H, et al. Outcome of HIV infected children with culture confirmed tuberculosis. Arch Dis Child 2005; 90:1171-4.
33. Kritzinger FE, den Boon S, Verver S, et al. No decrease in annual risk of tuberculosis infection in an endemic area in Cape Town, South Africa. Trop Med Int Health 2009; 14:136-42.